Connect with us

Hi, what are you looking for?

News

Beam: Opportunity Based On SCD Data Readout In 2024 (NASDAQ:BEAM)

Beam Therapeutics (NASDAQ:BEAM) has made significant progress in being able to advance its pipeline forward. That’s because it is in the process of running its phase 1/2 BEACON study, which is using BEAM-101 which is being advanced for the treatment

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube